Abbott Reviews 16.1 Percent Sales Development in Fourth Quarter Abbott today announced financial outcomes for the fourth quarter ended Dec Flagyl Oral . 31, 2007. Worldwide sales in the fourth quarter increased 16.1 % to $7.2 billion, including a favorable 4.5 % aftereffect of exchange rates. For the full-year 2007, worldwide product sales increased 15.3 % to $25.9 billion, including a favorable 3.2 % aftereffect of exchange rates. U.S. Pharmaceutical sales increased 16.6 % and international pharmaceutical product sales increased 21.3 %, driven by double-digit growth in HUMIRA, Kaletra and TriCor, and including $179 million of Niaspan sales. HUMIRA attained full-year worldwide sales more than $3 billion in 2007 and the company forecasts global product sales for HUMIRA of approximately $4 billion in 2008.
The assay can be one of five assays that run on the fully automated Abbott Prism Program. There are two types of HIV. HIV type 1 consists of several subgroups, including group M, the most typical subgroup of the virus in the United States, and group O, found primarily in Cameroon and the areas of West Africa. Related StoriesNew initiative launched to accelerate seek out effective HIV vaccineBrown University experts describe new solution to test HIV mutationsDespite reduced HIV/AIDS deaths, disease still persists in South AfricaHIV type 2 is found mostly in West Africa.